Amyloid deposition and its association with depressive symptoms and cognitive functions in late-life depression: A longitudinal study using amyloid- β PET images and neuropsychological measurements
Synaptic protein CSF levels relate to memory scores in individuals without dementia
Public Perceptions Related to Healthcare Preparedness to Anti-Amyloid Therapies for Alzheimer’s Disease in Japan
Perceptions about dementia clinical trials among underrepresented populations: A nationally representative survey of U.S. dementia caregivers
Sex-Specific Risk Factors and Clinical Dementia Outcomes for White Matter Hyperintensities in a large South Korean Cohort
Brain Topological Changes in Subjective Cognitive Decline and Associations with Amyloid Stages
Brain Iron in Signature Regions Relating to Cognitive Aging in Older Adults: The Taizhou Imaging Study
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
The cerebral blood flow response to neuroactivation is reduced in cognitively normal men with β-amyloid accumulation
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression